Min Wu Selected Research

8-((4-chlorophenyl)thio)cyclic-3',5'-GMP

4/2014	Type II cGMP-dependent protein kinase inhibits ligand‑induced activation of EGFR in gastric cancer cells.
12/2013	Type II cGMP-dependent protein kinase inhibits epidermal growth factor-induced phosphatidylinositol-3-kinase/Akt signal transduction in gastric cancer cells.
1/2013	PKG II inhibits EGF/EGFR-induced migration of gastric cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Min Wu Research Topics

Disease

241	Neoplasms (Cancer) 11/2022 - 01/2002
76	Infections 04/2022 - 12/2009
69	Inflammation (Inflammations) 01/2022 - 02/2002
33	Neoplasm Metastasis (Metastasis) 06/2022 - 08/2002
26	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2005
26	Carcinogenesis 01/2022 - 08/2002
22	Atherosclerosis 01/2022 - 01/2006
21	Lung Neoplasms (Lung Cancer) 12/2020 - 05/2002
20	Fibrosis (Cirrhosis) 04/2022 - 07/2002
20	COVID-19 01/2022 - 05/2020
19	Chronic Hepatitis B 01/2022 - 12/2009
19	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2013
18	Carcinoma (Carcinomatosis) 11/2021 - 05/2002
17	Asthma (Bronchial Asthma) 02/2022 - 01/2005
17	Bacterial Infections (Bacterial Infection) 01/2021 - 01/2009
16	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2022 - 01/2002
15	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 08/2002
14	Melanoma (Melanoma, Malignant) 05/2022 - 04/2002
13	Leukemia 05/2022 - 03/2005
13	Hypertension (High Blood Pressure) 01/2022 - 03/2006
13	Esophageal Squamous Cell Carcinoma 03/2008 - 04/2003
12	Obesity 07/2022 - 11/2009
12	Body Weight (Weight, Body) 04/2022 - 07/2012
12	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2012
12	Colorectal Neoplasms (Colorectal Cancer) 11/2021 - 10/2013
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2014
10	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2022 - 12/2013
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 11/2013
10	Hemorrhage 01/2022 - 02/2012
10	Hypoxia (Hypoxemia) 11/2020 - 11/2005
9	Pseudomonas Infections 01/2021 - 02/2008
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2022 - 08/2008
8	Wounds and Injuries (Trauma) 04/2022 - 01/2010
8	Sepsis (Septicemia) 01/2022 - 11/2015
8	Lung Injury 01/2022 - 04/2005
8	Autoimmune Diseases (Autoimmune Disease) 12/2021 - 08/2002
8	Glioma (Gliomas) 11/2021 - 09/2011
8	Colitis 10/2021 - 01/2018
8	Ischemia 10/2021 - 11/2011
8	Necrosis 10/2017 - 05/2011
7	Insulin Resistance 07/2022 - 11/2009
7	Hepatitis B 01/2022 - 05/2013
7	Ischemic Stroke 01/2022 - 01/2016
7	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 11/2003
7	Colonic Neoplasms (Colon Cancer) 05/2021 - 01/2012
7	Adenocarcinoma of Lung 04/2021 - 02/2004
7	Pneumonia (Pneumonitis) 01/2021 - 09/2003

Drug/Important Bio-Agent (IBA)

70	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2002
60	Pharmaceutical PreparationsIBA 08/2022 - 09/2005
39	Biomarkers (Surrogate Marker)IBA 11/2022 - 04/2003
37	Messenger RNA (mRNA)IBA 01/2022 - 08/2002
33	CytokinesIBA 01/2022 - 09/2003
24	MicroRNAs (MicroRNA)IBA 08/2022 - 01/2012
23	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2002
22	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 01/2007
19	Complementary DNA (cDNA)IBA 08/2016 - 08/2002
18	EnzymesIBA 02/2022 - 05/2002
18	LipidsIBA 01/2020 - 09/2008
17	Biological ProductsIBA 04/2021 - 08/2002
16	Small Interfering RNA (siRNA)IBA 02/2022 - 06/2006
16	Phosphotransferases (Kinase)IBA 06/2020 - 09/2009
14	GlucocorticoidsIBA 01/2022 - 09/2009
13	Peptides (Polypeptides)IBA 02/2022 - 09/2002
13	Immunoglobulin G (IgG)IBA 01/2022 - 10/2003
12	Antiviral Agents (Antivirals)IBA 04/2022 - 08/2010
12	Transcription Factors (Transcription Factor)IBA 01/2022 - 12/2002
12	PolymersIBA 01/2022 - 11/2013
12	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 01/2002
11	Epidermal Growth Factor (EGF)IBA 11/2022 - 06/2009
11	AntibodiesIBA 06/2022 - 01/2010
11	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2022 - 03/2012
11	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2010
11	CollagenIBA 01/2022 - 12/2013
11	VaccinesIBA 12/2021 - 12/2009
11	Histones (Histone)IBA 01/2021 - 09/2012
10	ErbB Receptors (EGF Receptor)IBA 11/2022 - 09/2011
10	Protein Kinases (Protein Kinase)IBA 05/2022 - 05/2002
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2022 - 06/2008
9	InterferonsIBA 01/2022 - 09/2005
9	Long Noncoding RNAIBA 04/2021 - 01/2018
9	Gemcitabine FDA Link 01/2019 - 02/2004
8	ChromatinIBA 05/2022 - 01/2016
8	Monoclonal AntibodiesIBA 02/2022 - 03/2016
8	InflammasomesIBA 01/2022 - 10/2014
8	Circular RNAIBA 01/2022 - 05/2019
8	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2003
8	CholesterolIBA 01/2022 - 02/2008
8	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 11/2009
8	LigandsIBA 05/2021 - 01/2013
8	Matrix Metalloproteinases (MMPs)IBA 10/2020 - 01/2006
8	Therapeutic UsesIBA 09/2020 - 01/2005
7	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 02/2016
7	Annexin A2 (Annexin II)IBA 01/2021 - 07/2003

Therapy/Procedure

113	Therapeutics 09/2022 - 08/2002
22	Immunotherapy 02/2022 - 04/2015
20	Drug Therapy (Chemotherapy) 01/2022 - 10/2011
8	Radiotherapy 02/2022 - 06/2014
8	Precision Medicine 02/2022 - 01/2015
8	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 04/2008
7	Punctures 01/2022 - 01/2016